4.7 Article

Clinical Implications of a New DDX58 Pathogenic Variant That Causes Lupus Nephritis due to RIG-I Hyperactivation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Genetics & Heredity

DDX58(RIG-I)-related disease is associated with tissue-specific interferon pathway activation

Lev Prasov et al.

Summary: Singleton-Merten syndrome (SGMRT) is a rare immunogenetic disorder characterized by features such as juvenile open-angle glaucoma, psoriasiform skin rash, and aortic calcifications. A study identified a novel DDX58 variant, expanding the genotypic spectrum of the disease. Furthermore, detailed ocular and dermatological phenotypes were described for the first time, shedding light on the molecular pathogenesis of SGMRT.

JOURNAL OF MEDICAL GENETICS (2022)

Review Urology & Nephrology

Type I interferon-related kidney disorders

Lorenzo Lodi et al.

Summary: Type I interferon mediates tissue damage in kidney disorders, affecting the function of various renal cell types. These disorders can cause renal dysfunction and share pathological features. Defining the classification, pathogenic mechanisms, and histopathological patterns of IFN-I-related kidney disorders is crucial for diagnosis and treatment.

KIDNEY INTERNATIONAL (2022)

Article Biochemistry & Molecular Biology

A loosened gating mechanism of RIG-I leads to autoimmune disorders

Yixuan Lei et al.

Summary: This study investigated how subtle conformational changes in the helicase insertion domain (HEL2i) of RIG-I can impair ATPase and RNA proofreading activities, leading to increased immunopathy. The findings highlight the importance of HEL2i as a checkpoint in controlling antiviral innate immunity and autoimmune diseases.

NUCLEIC ACIDS RESEARCH (2022)

Review Immunology

IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis

Xuewei Ding et al.

Summary: Lupus nephritis (LN) is a common complication of systemic lupus erythematosus (SLE) and cell-free nucleic acids play a key role in its pathogenesis. Resident renal cells can produce type I interferons (IFN-I), which is associated with renal fibrosis. Targeting IFN-I may be a novel approach for LN treatment.

FRONTIERS IN IMMUNOLOGY (2021)

Editorial Material Allergy

JAK inhibition in the type I interferonopathies

Yanick J. Crow et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Rheumatology

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

Peter Nash et al.

Summary: The use of Janus kinase inhibitors (JAKi) in immune-mediated inflammatory diseases has been extensively reviewed to provide guidance on efficacy and safety. A consensus statement was formed by an expert committee, evaluating 26 key points in six areas, with high levels of agreement and evidence-based recommendations. This consensus offers valuable insights for the practical management of JAKi in clinical practice.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Multidisciplinary Sciences

A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1

Panfeng Tao et al.

NATURE (2020)

Review Medicine, General & Internal

New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and Beyond

Erkan Demirkaya et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Immunology

Interstitial Lung Disease and Psoriasis in a Child With Aicardi-Goutieres Syndrome

Shaoling Zheng et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Type I interferon in the pathogenesis of systemic lupus erythematosus

Mariana Postal et al.

CURRENT OPINION IN IMMUNOLOGY (2020)

Article Immunology

DDX58 and Classic Singleton-Merten Syndrome

Carlos R. Ferreira et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2019)

Article Urology & Nephrology

COPA Syndrome as a Cause of Lupus Nephritis

Siham Boulisfane-El Khalifi et al.

KIDNEY INTERNATIONAL REPORTS (2019)

Article Biochemistry & Molecular Biology

Development of a Validated Interferon Score Using NanoString Technology

Hanna Kim et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)

Review Immunology

Regulation of RiG-I Activation by K63-Linked Polyubiquitination

Masaaki Okamoto et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Immunology

Janus Kinase inhibitor Baricitinib Modulates human innate and adaptive immune system

Satoshi Kubo et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Immunology

Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity

Yiliu Liu et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Genetics & Heredity

Further evidence for specific IFIH1 mutation as a cause of Singleton-Merten syndrome with phenotypic heterogeneity

Maria Pettersson et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)

Review Microbiology

Viral evasion of intracellular DNA and RNA sensing

Ying Kai Chan et al.

NATURE REVIEWS MICROBIOLOGY (2016)

Article Genetics & Heredity

Mutations in DDX58, which Encodes RIG-I, Cause Atypical Singleton-Merten Syndrome

Mi-Ae Jang et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2015)

Article Genetics & Heredity

A Specific IFIH1 Gain-of-Function Mutation Causes Singleton-Merten Syndrome

Frank Rutsch et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2015)

Article Rheumatology

IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency

Lien Van Eyck et al.

ARTHRITIS & RHEUMATOLOGY (2015)

Article Medicine, General & Internal

Early- Onset Stroke and Vasculopathy Associated with Mutations in ADA2

Qing Zhou et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Genetics & Heredity

Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus

Sulaiman M. Al-Mayouf et al.

NATURE GENETICS (2011)

Article Multidisciplinary Sciences

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

EC Baechler et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)